Expired activity
Please go to the PowerPak homepage and select a course.

Changing the Treatment Landscape: Embracing Long-Acting Injectable Antipsychotics

Presented by Creative Educational Concepts, Inc.
Supported through independent educational grants from Alkermes and Indivior.

Release date:

June 17, 2019

Expiration date:

June 17, 2020

Learning Objectives

At the conclusion of this application-based activity, participants will be able to:

  1. Review the evidence base of long-acting injectable antipsychotics (LAI) compared to oral antipsychotics with regards to adherence, hospitalization, relapse, and mortality.
  2. Identify the role of LAIs in the treatment continuum and discuss their use earlier in the schizophrenia disease course.
  3. Compare LAIs with regard to pharmacokinetic profiles, loading dose strategies, and chronic dosing.
  4. Incorporate LAIs into treatment regimens using case-based examples.


This activity is complimentary.





Target Audience

This activity is designed to meet the educational needs psychiatric and neurologic pharmacists with an interest
in long-acting injectable antipsychotics.


Megan Ehret, PharmD, MS, BCPP
University of Maryland School of Pharmacy
Baltimore, MD


In accordance with the Food and Drug Administration, the speakers have disclosed that there is the potential for discussions concerning off-label uses of a commercial product/device during this educational activity.

Any person who may contribute to the content of this continuing education activity must disclose relevant relationships (and any known relationships of their spouse/partner) with commercial interests whose products or services are discussed in educational content. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Relevant relationships include receiving from a commercial interest research grants, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.

Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of educational content.


Joan B. Fowler, PharmD, BCPP–has no relevant financial relationships to disclose in relation to the content of this activity.


Megan Ehret, PharmD, MS, BCPP–has no relevant financial relationships to disclose in relation to the content of this activity.

Peer Reviewer:

Steven C. Stoner, PharmD, BCPP–has disclosed that he is a consultant for Alkermes and a member of the speakers' bureau for Neurocrine Biosciences, Inc.

Accreditation Statement

jointly accredited by (ACCME)In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Pharmacy (ACPE)

This application-based activity is approved for 1.0 contact hour of continuing pharmacy education credit (JA0007101-0000-19-012-H01-P).
Upon completion of the post-test, pharmacy credit will be reported directly to the National Association of Boards of Pharmacy®(NABP®) CPE Monitor® electronic CE tracking system within 30 business days.

Activity Instructions

To receive a statement of credit, you must:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Review the full content of the activity and reflect upon its teaching.
  3. Complete the questions and evaluation at the end of the activity.
  4. You must have a passing score of 75% on the post-test. You will have two (2) opportunities to complete the post-test.